Human catechol-O-methyltransferase down-regulation by estradiol

Neuropharmacology

Volumn 45, Issue 7, 2003, Pages 1011-1018

  Jiang, H ^a   Xie, T ^a   Ramsden, D B ^b   Ho, S L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

17 estradiol; Catechol O methyltransferase; Dopamine; Estrogen receptor; Estrogen response element; Parkinson's disease; S adenosyl L methionine

Indexed keywords

ANTIBODY; CATECHOL METHYLTRANSFERASE; DNA FRAGMENT; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; MESSENGER RNA;

ARTICLE; CELL CULTURE; CELL LINE; CELL NUCLEUS; CULTURE MEDIUM; ELECTROPHORESIS; ENZYME ACTIVITY; ENZYME REGULATION; GENE CONTROL; GENE EXPRESSION; GLIA CELL; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOADSORPTION; IMMUNOPRECIPITATION; INTERMETHOD COMPARISON; MENOPAUSE; NORTHERN BLOTTING; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RADIOENZYMATIC ASSAY; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

EID: 0142027141     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(03)00286-7     Document Type: Article

References (33)

1. An J., Ribeiro R.C., Webb P., Gustafsson J.-A., Kushner P.J., Baxter J.D., Leitman D.C. Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proceedings of the National Academy of Sciences of the United States of America. 96:1999;15161-15166.
2. Boudikova B., Szumlanski C., Maidak B., Weinshilboum R. Human liver catechol-O-methyltransferase pharmacogenetics. Clinical Pharmacology and Therapeutics. 48:1990;381-389.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry. 72:1976;248-254.
4. Cariou S., Donovan J.C., Flanagan W.M., Milic A., Bhattacharya N., Slingerland J.M. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 97:2000;9042-9046.
5. Diel P., Smolnikar K., Michna H. The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL-2 than tamoxifen in MCF-7 cells. Breast Cancer Research and Treatment. 58:1999;87-97.
6. Dukes M., Miller D., Wakeling A.E., Waterton J.C. Antiuterotrophic effects of a pure antioestrogen, ICI 182,780: magnetic resonance imaging of the uterus in ovariectomized monkeys. Journal of Endocrinology. 135:1992;239-247.
7. Dukes M., Waterton J.C., Wakeling A.E. Antiuterotrophic effects of the pure antioestrogen ICI 182,780 in adult female monkeys (Macaca nemestrina): quantitative magnetic resonance imaging. Journal of Endocrinology. 138:1993;203-210.
8. Fahndrich E., Coper H., Christ W., Helmchen H., Muller-Oerlinghausen B., Pietzcker A. Erythrocyte COMT-activity in patients with affective disorders. Acta Psychiatrica Scandinavica. 61:1980;427-437.
9. Hager G.L., Lim C.S., Elbi C., Baumann T. Trafficking of nuclear receptors in living cells. Journal of Steroid Biochemistry and Molecular Biology. 74:2000;249-254.
10. Heikkinen H., Varhe A., Laine T., Puttonen J., Kela M., Kaakkola S., Reinikainen K. Entacapone improves the availability of L-dopa in plasma by decreasing its peripheral metabolism independent of L-dopa/carbidopa dose. British Journal of Clinical Pharmacology. 54:2002;363-371.
11. Jakacka M., Ito M., Weiss J., Chien P.Y., Gehm B.D., Jameson J.L. Estrogen receptor binding to DNA is not required for its activity through the non-classical AP1 pathway. Journal of Biological Chemistry. 276:2001;13615- 13621.
12. Jori A., Cecchetti G. Homovanillic acid levels in rat striatum during the oestrous cycle. Journal of Endocrinology. 58:1973;341-342.
13. Karege F., Bovier P., Gaillard J.M., Tissot R. The decrease of erythrocyte catechol-O-methyltransferase activity in depressed patients and its diagnostic significance. Acta Psychiatrica Scandinavica. 76:1987;303-308.
14. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.-A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 138:1997;863-870.
15. Kumar V., Chambon P. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell. 55:1988;145-156.
16. Kurebayashi S., Miyashita Y., Hirose T., Kasayama S., Akira S., Kishimoto T. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor. Journal of Steroid Biochemistry and Molecular Biology. 60:1997;11-17.
17. Kyte J., Doolittle R.F. A simple method for displaying the hydropathic character of a protein. Journal of Molecular Biology. 157:1982;105-132.
18. Mannisto P.T., Ulmanen I., Lundstrom K., Taskinen J., Tenhunen J., Tilgmann C., Kaakkola S. Characteristics of catechol-O-methyltransferase (COMT) and properties of selective COMT inhibitors. Progress in Drug Research. 39:1992;291-350.
19. Molloy P.L. Electrophoretic mobility shift assays. Methods in Molecular Biology. 130:2000;235-246.
20. Parsons R.B., Ramsden D.B., Waring R.H., Barber P.C., Williams A.C. Hepatic localisation of rat cysteine dioxygenase. Journal of Hepatology. 29:1998;595-602.
21. Parvez S., Ismahan G., Raza-Bukhari A., Youdim M.B. Activity of catechol-o-methyltransferase in brain regions and adrenal gland during the oestrus cycle. Journal of Neural Transmission. 42:1978;305-312.
22. Philippu G., Hoo J.J., Milech U., Argarwall D.P., Schrappe O., Goedde H.W. Catechol-O-methyltransferase of erythrocytes in patients with endogenous psychoses. Psychiatry Research. 4:1981;139-146.
23. Puzynski S., Hauptmann M., Zaluska M. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. III. Platelet monoamine oxidase activity in endogenous depression. Acta Psychiatrica Scandinavica. 67:1983;101-108.
24. Russell K.S., Hung M.C. Transcriptional repression of the neu protooncogene by estrogen stimulated estrogen receptor. Cancer Research. 52:1992;6624-6629.
25. Sambrook J., Fritsch E., Maniatis T. Detection and analysis of proteins expressed from cloned genes. Molecular Cloning - A Laboratory Manual. 1989;18 Cold Spring Harbor Laboratory Press, New York.
26. Shanmugam M., Krett N.L., Maizels E.T., Cutler R.E. Jr., Peters C.A., Smith L.M., O'Brien M.L., Park-Sarge O.K., Rosen S.T., Hunzicker-Dunn M. Regulation of protein kinase C delta by estrogen in the MCF-7 human breast cancer cell line. Molecular Cell Endocrinology. 148:1999;109-118.
27. Sonnenberg J.L., Mitchelmore C., Macgregor-Leon P.F., Hempstead J., Morgan J.I., Curran T. Glutamate receptor agonists increase the expression of Fos, Fra and AP-1 DNA binding activity in the mammalian brain. Journal of Neuroscience Research. 24:1989;72-80.
28. Tenhunen J., Salminen M., Lundstrom K., Kiviluoto T., Savolainen R., Ulmanen I. Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. European Journal of Biochemistry. 223:1994;1049-1059.
29. Tsang K.L., Ho S.L., Lo S.K. Estrogen improves motor disability in Parkinsonian postmenopausal women with motor fluctuations. Neurology. 54:2000;2292-2298.
30. Wakeling A.E., Dukes M., Bowler J. A potent specific pure antiestrogen with clinical potential. Cancer Research. 51:1991;3867-3873.
31. Watanabe T., Inoue S., Ogawa S., Ishii Y., Hiroi H., Ikeda K., Orimo A., Muramatsu M. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors alpha and beta. Biochemical And Biophysical Research Communication. 236:1997;140-145.
32. Weinshilboum R. Pharmacogenetics of methylation: relationship to drug metabolism. Clinical Biochemistry. 21:1988;201-210.
33. Xie T., Ho S.L., Ramsden D.B. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Molecular Pharmacology. 56:1999;31-38.